Ascend Performance Materials announced recently that it has submitted its first FDA 510(k) for clearance to market its patent-pending Acteev™ technology in the U.S. in a medical device: a surgical mask under a new brand called Acteev Biodefend™. Independent laboratory testing has found Acteev materials to achieve greater than 99 percent efficacy at deactivating bacteria, fungi and viruses, including SARS-CoV-2.
“We’ve partnered with independent labs for comprehensive testing and have reallocated resources to ready ourselves for world-scale production upon receiving regulatory clearance,” said Vikram Gopal, Ph.D., Ascend’s chief technology officer.
The testing was conducted following the protocols of ISO, ASTM or other international standards organizations. Acteev technology, covered by more than 15 patent families, embeds active zinc ions into the matrix of a specialty polymer.
“What is unique about Acteev is the marriage between the antimicrobial ingredient like zinc and the specialty polymer that keeps the zinc ions active and bound at all times,” Dr. Gopal said. “Because it isn’t a simple topical finish or coating, the antimicrobial protection can last much longer. It will not flake off or be worn away. And, unlike some other antimicrobials, zinc is environmentally friendly.”
Acteev technology has been tested in multiple end forms, including knit and woven fabrics; engineered plastics; and nanofiber, meltblown and spunbond nonwoven materials.
“The current global scarcity of pathogen-resistant materials is not going to end unless scientists and engineers look for novel ways to face the challenge, and we are proud to submit Acteev Biodefend as a potential solution,” Dr. Gopal said.
Ascend Performance Materials is a provider of plastics, fibers and chemicals and is headquartered in Houston, Texas.